Monitor HKPD's stock price post-split to see if it sustains above the $1 minimum bid price. If the price fails to hold, delisting risk increases materially. The company's explicit caution about compliance uncertainty suggests a high probability of continued listing challenges.
Price Chart
Executive Summary
Cellyan Biotechnology announced a 1-for-20 reverse stock split effective October 26, 2026, aimed at regaining compliance with Nasdaq's minimum bid price requirement for continued listing. The split consolidates every 20 ordinary shares into one, with fractional shares rounded up, and does not alter shareholders' percentage interests. The company explicitly warns there is no assurance it will regain or maintain compliance.
Key Facts
- 1-for-20 reverse stock split effective at market open on October 26, 2026
- Split is primarily intended to regain compliance with Nasdaq minimum bid price requirement
- Company states there can be no assurance it will regain or maintain compliance
- Fractional shares rounded up to nearest whole share at participant level
- Par value changes from $0.001 to $0.02 per share post-split
- Trading symbol remains HKPD; new CUSIP is G6365B112
- Approved by board of directors
Financial Impact
No financial figures provided; reverse split is a mechanical share consolidation with no change to shareholder percentage interests or company fundamentals
Risk Factors
- Failure to regain or maintain Nasdaq minimum bid price compliance could lead to delisting
- Reverse splits often signal financial distress and can be followed by further price declines
- No operational or financial improvement announced alongside the split
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-111190 |
| Document: ea030894801ex99-1.htm | 0001213900-26-111190 |
| Document: 0001213900-26-111190-index-headers.html | 0001213900-26-111190 |
| Document: 0001213900-26-111190-index.html | 0001213900-26-111190 |
| Document: 0001213900-26-111190.txt | 0001213900-26-111190 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.1020 $0.0960 | ▲ +5.88% | ▲ +4.70% | — |
Sep 23, 2026 4w ago | 6-K | $0.1207 $0.1118 | ▼ −7.37% | ▼ −7.92% | — |
Sep 23, 2026 4w ago | 6-K | $0.1192 $0.1207 | ▲ +1.26% | ▲ +1.34% | — |
Jun 25, 2026 17w ago | EFFECT | $0.3710 $0.3610 | ▲ +2.70% | ▲ +1.97% | — |
Apr 9, 2026 28w ago | EFFECT | $0.5570 $0.6220 | ▲ +11.67% | ▲ +11.73% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers